Skip to main content
main-content

06-26-2018 | Cardiovascular outcomes | ADA 2018 | Video

Expert commentary: Legacy cardioprotective effect of intensive glycemic control does not last

Medha Munshi comments on the VADT trial, showing that the cardioprotective effect of intensive glycemic control in patients with type 2 diabetes disappears after 15 years (3:04).

Read the accompanying news story here

More on this topic

image credits